The Medtronic Foundation and Children’s Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries

April 7, 2021

The Medtronic Foundation: As the World Health Organization spearheads a global campaign on equity this World Health Day, the Medtronic Foundation and Children’s HeartLink (CHL) are announcing a $2.5 million, three-year, outcomes-based partnership to address congenital heart disease in children with a focus on reducing disparities in access to care and quality patient outcomes, and meaningful employee engagement.

This partnership continues a rich collaborative legacy across the organizations and is made in honor of Omar Ishrak, former chairman and CEO, Medtronic and former board member of the Medtronic Foundation, a true champion of impact-driven philanthropy focusing on the underserved. View video.

“Every child with congenital heart disease deserves access to quality pediatric heart care,” said Paurvi Bhatt, Medtronic Foundation president. “Together with Children’s HeartLink, the Medtronic Foundation is in a unique position to mark World Health Day by ensuring more children get equitable care and have the opportunity to survive and thrive.”

Worldwide, the leading cause of death from a non-communicable disease before age 30 is congenital heart disease.1 Ninety percent of children born with heart disease don’t have access to the care they need, and most of those children live in low- and middle-income countries.2

“We are especially proud because this partnership brings together both the financial resources from the Medtronic Foundation and the time and skills of our passionate Medtronic employees. Together, we can improve quality care and patient outcomes,” said Geoff Martha, Medtronic chairman and CEO, and member of, CHL board of directors.

“We are honored to partner with Medtronic Foundation and help thousands of more children, and the impact of health worker training will be felt for generations to come,” said Jackie Boucher, Children’s HeartLink president. “This partnership gives 10,000 children the chance for a joyful childhood and the opportunity to lead productive adult lives.”

Specifically, the partners aim to actively address inequities in congenital heart surgery access and outcomes over three years by:

  • Strengthening hospital capacity and training 10,000 health workers (pediatric surgeons, pediatric cardiologists, and nurses) to provide congenital heart disease surgery and quality outcomes for 10,000 children.
  • Supporting CHL’s strategic growth and innovation, enabling the organization to scale in underserved countries – doubling its impact between 2025 and 2030 by adding five new partner hospitals over the next 3 years.
  • Reducing health disparities in access to care through a mixed-method study with partner hospitals, revealing key differences by gender, income, and socioeconomic status of families, and developing site-specific equity dashboards to foster continuous quality improvement.
  • Tapping Medtronic employees’ skills and talents in domains such as clinical and medical education and training, technology development, market access, data science, and analytics.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.